Business Description
Avacta Group PLC
ISIN : GB00BYYW9G87
Total Employee Number:
75Description
Avacta Group PLC is a clinical-stage life sciences company expanding the reach of potent cancer therapies with the pre-CISION platform. pre-CISION is a proprietary warhead delivery system based on a tumor-specific protease (fibroblast activation protein or FAP) that is designed to concentrate potent warheads in the tumor microenvironment while sparing normal tissues. The company's pipeline consists of pre-CISION peptide drug conjugates (PDC) or Affimer drug conjugates (AffDC) that leverage the tumor-specific release mechanism, providing benefits over traditional antibody drug conjugates. The firm has one reportable segment, Therapeutics, which is engaged in the development of novel cancer therapies harnessing its proprietary technology. Geographically, it derives revenue from South Korea.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.13 | |||||
Equity-to-Asset | 0.08 | |||||
Debt-to-Equity | 6.03 | |||||
Debt-to-EBITDA | -0.54 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -4.19 | |||||
Beneish M-Score | 4.14 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 20.4 | |||||
3-Year EPS without NRI Growth Rate | 6.6 | |||||
3-Year FCF Growth Rate | 2.6 | |||||
3-Year Book Growth Rate | -57.8 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 22.11 | |||||
9-Day RSI | 37.3 | |||||
14-Day RSI | 45.05 | |||||
3-1 Month Momentum % | 12 | |||||
6-1 Month Momentum % | 25.75 | |||||
12-1 Month Momentum % | 155.55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.89 | |||||
Quick Ratio | 0.89 | |||||
Cash Ratio | 0.64 | |||||
Days Sales Outstanding | 9666.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -18.5 | |||||
Shareholder Yield % | -5.54 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -26053.1 | |||||
Net Margin % | -34169.91 | |||||
EBITDA Margin % | -24592.04 | |||||
FCF Margin % | -23795.39 | |||||
OCF Margin % | -23748.68 | |||||
ROE % | -973.33 | |||||
ROA % | -108.33 | |||||
ROIC % | -93.58 | |||||
3-Year ROIIC % | 5.1 | |||||
ROC (Joel Greenblatt) % | -478.17 | |||||
ROCE % | -560.08 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 121.67 | |||||
EV-to-EBIT | -11.7 | |||||
EV-to-EBITDA | -12.24 | |||||
EV-to-Revenue | 3009.75 | |||||
EV-to-Forward-Revenue | 9.63 | |||||
EV-to-FCF | -12.67 | |||||
Price-to-GF-Value | 1.54 | |||||
Earnings Yield (Greenblatt) % | -8.55 | |||||
FCF Yield % | -7.85 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:AVCTF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Avacta Group PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.152 | ||
| EPS (TTM) ($) | -0.13 | ||
| Beta | -0.7531 | ||
| 3-Year Sharpe Ratio | 0.17 | ||
| 3-Year Sortino Ratio | 0.28 | ||
| Volatility % | 83.61 | ||
| 14-Day RSI | 45.05 | ||
| 14-Day ATR ($) | 0.006521 | ||
| 20-Day SMA ($) | 1 | ||
| 12-1 Month Momentum % | 155.55 | ||
| 52-Week Range ($) | 0.4011 - 1.23 | ||
| Shares Outstanding (Mil) | 468.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Avacta Group PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Avacta Group PLC Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2026 | 2026-09-30 13:00 | In 98 days | ||
| Second quarter earnings results for 2026 | 2026-09-30 | In 97 days | ||
| General meeting for 2025 | 2026-06-22 08:00 | 1.00 (+0.00%) | ||
| Annual report for 2025 | 2026-05-29 | 1.00 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-05-19 13:00 | 1.23 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-05-19 | 1.23 (+0.00%) | ||
| 46th Annual TD Cowen Health Care Conference | 2026-03-03 09:10 | 0.93 (+0.00%) | ||
| Second quarter earnings conference call for 2025 | 2025-09-30 13:00 | 0.75 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-09-30 | 0.75 (+0.00%) | ||
| General meeting for 2024 | 2025-07-02 09:00 | 0.40 (+0.00%) |
Show
Entries
Avacta Group PLC Frequently Asked Questions
What is Avacta Group PLC(AVCTF)'s stock price today?
The current price of AVCTF is $1.00. The 52 week high of AVCTF is $1.23 and 52 week low is $0.40.
When is next earnings date of Avacta Group PLC(AVCTF)?
The next earnings date of Avacta Group PLC(AVCTF) is 2026-09-30 Est..
Does Avacta Group PLC(AVCTF) pay dividends? If so, how much?
Avacta Group PLC(AVCTF) does not pay dividend.
Guru Commentaries on OTCPK:AVCTF
No articles.
Press Release
Articles on Avacta Group PLC
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers